calcium channel, voltage-dependent, gamma subunit 5 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Protein Tyrosine Kinase, EGF Receptor |
66% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
BITHIONOL |
Muscarinic M4 |
66% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
GRAMICIDIN |
Protein Tyrosine Kinase, EGF Receptor |
66% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type X, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type IV, beta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type III, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type II, beta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type I, beta |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
sodium channel, voltage-gated, type I, alpha |
BROMOCRIPTINE |
Sodium Channel, Site 2 |
78% |
6.692uM |
6.105uM |
View
|
Sigma-2 Receptor |
EPERISONE |
Sigma2 |
78% |
1.064uM |
.655uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CITALOPRAM |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.025uM |
.996uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CITALOPRAM |
Adrenergic, Norepinephrine Transporter |
78% |
2.196uM |
2.178uM |
View
|
thromboxane A synthase 1 |
INDINAVIR |
Thromboxane Synthetase |
78% |
1.851uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
INDINAVIR |
Thromboxane Synthetase |
78% |
1.851uM |
NoneNone |
View
|
adrenergic receptor, beta 2 |
MONTELUKAST |
Adrenergic beta2 |
78% |
3.488uM |
2.398uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Serotonin 5-HT2B |
78% |
1.508uM |
.96uM |
View
|
Sigma-2 Receptor |
LOPERAMIDE |
Sigma2 |
78% |
1.379uM |
.848uM |
View
|
opioid receptor, sigma 1 |
PROPRANOLOL |
Sigma1 |
78% |
2.87uM |
1.206uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type I, beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type I, alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type IV, beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel associated protein 1 |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel associated protein 2 |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type III, beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type I, alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type III, beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type I, beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type II, beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
CITALOPRAM |
Sodium Channel, Site 2 |
77% |
2.641uM |
2.409uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
MIANSERIN |
Serotonin 5-HT3 |
77% |
2.746uM |
.617uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
MIANSERIN |
Serotonin 5-HT3 |
77% |
2.746uM |
.617uM |
View
|
adrenergic receptor, beta 2 |
LOPERAMIDE |
Adrenergic beta2 |
77% |
3.005uM |
2.066uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE |
Serotonin 5-HT2B |
77% |
1.549uM |
.986uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
sodium channel associated protein 2 |
PUROMYCIN |
Sodium Channel, Site 2 |
12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SULCONAZOLE |
Calcium Channel Type L, Dihydropyridine |
77% |
2.427uM |
1.56uM |
View
|
phosphodiesterase 3B |
DANAZOL |
Phosphodiesterase PDE3 |
77% |
2.535uM |
NoneNone |
View
|
phosphodiesterase 3A |
DANAZOL |
Phosphodiesterase PDE3 |
77% |
2.535uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
SULCONAZOLE |
Protein Tyrosine Kinase, Fyn |
77% |
3.704uM |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIETHYLSTILBESTROL |
Calcium Channel Type L, Phenylalkylamine |
77% |
3.761uM |
3.65uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
OXICONAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.7269uM |
2.6512uM |
View
|
cholinergic receptor, muscarinic 1 |
OXICONAZOLE |
Muscarinic M1 |
76% |
4.7364uM |
1.1407uM |
View
|
Sigma-2 Receptor |
PRAMOXINE |
Sigma2 |
76% |
1.029uM |
.633uM |
View
|
thromboxane A synthase 1 |
AMPRENAVIR |
Thromboxane Synthetase |
76% |
6.727uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
AMPRENAVIR |
Thromboxane Synthetase |
76% |
6.727uM |
NoneNone |
View
|
melanocortin 4 receptor |
CETYLPYRIDINIUM BROMIDE |
Melanocortin MC4 |
76% |
5.081uM |
4.886uM |
View
|
dopamine receptor D1A |
RALOXIFENE |
Dopamine D1 |
76% |
3.864uM |
1.932uM |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
NATEGLINIDE |
Potassium Channel [KATP] |
76% |
1.667uM |
.189uM |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
NATEGLINIDE |
Potassium Channel [KATP] |
76% |
1.667uM |
.189uM |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
NATEGLINIDE |
Potassium Channel [KATP] |
76% |
1.667uM |
.189uM |
View
|
lymphocyte protein tyrosine kinase (mapped) |
TRIBROMSALAN |
Protein Tyrosine Kinase, Lck |
76% |
5.015uM |
NoneNone |
View
|
tachykinin receptor 2 |
CLOMIPHENE |
Tachykinin NK2 |
76% |
4.525uM |
1.508uM |
View
|
adrenergic receptor, beta 1 |
ATENOLOL |
Adrenergic beta1 |
76% |
1.313uM |
.758uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
sodium channel, voltage-gated, type III, beta |
PUROMYCIN |
Sodium Channel, Site 2 |
12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PERGOLIDE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.913uM |
.887uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
CYPROHEPTADINE |
Serotonin 5-HT1B |
76% |
2.778uM |
1.263uM |
View
|
cysteinyl leukotriene receptor 1 |
GW-1929 |
Leukotriene D4 |
76% |
10.91uM |
5.455uM |
View
|
cysteinyl leukotriene receptor 1 |
GW-1929 |
Leukotriene D4 |
76% |
10.91uM |
5.455uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
METOCLOPRAMIDE |
Serotonin 5-HT2C |
76% |
2.383uM |
1.248uM |
View
|
histamine receptor H 2 |
ECONAZOLE |
Histamine H2 |
76% |
1.592uM |
1.565uM |
View
|
melanocortin 3 receptor |
MICONAZOLE |
Melanocortin MC3 |
76% |
18.485uM |
16.132uM |
View
|
melanocortin 3 receptor |
MICONAZOLE |
Melanocortin MC3 |
76% |
18.485uM |
16.132uM |
View
|
cholinergic receptor, muscarinic 4 |
CIGLITAZONE |
Muscarinic M4 |
76% |
16.224uM |
2.263uM |
View
|
cysteinyl leukotriene receptor 1 |
DIETHYLSTILBESTROL |
Leukotriene D4 |
76% |
17.745uM |
8.872uM |
View
|
cysteinyl leukotriene receptor 1 |
DIETHYLSTILBESTROL |
Leukotriene D4 |
76% |
17.745uM |
8.872uM |
View
|
androgen receptor |
ESTRONE |
Testosterone |
76% |
11.617uM |
7.745uM |
View
|
Cytochrom P450-2D6 monooxygenase |
AJMALINE |
CYP450-2D6 Inhibition |
76% |
1uM |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
3-METHYLCHOLANTHRENE |
CYP450-1A2 Inhibition |
76% |
.3uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
PACLITAXEL |
Protein Tyrosine Kinase, Fyn |
76% |
23.906uM |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
TANNIC ACID |
Protein Tyrosine Kinase, Lck |
76% |
.079uM |
NoneNone |
View
|
leukotriene C4 synthase |
TANNIC ACID |
Leukotriene C4 Synthetase |
76% |
2.715uM |
NoneNone |
View
|
leukotriene C4 synthase |
TANNIC ACID |
Leukotriene C4 Synthetase |
76% |
2.715uM |
NoneNone |
View
|
dopamine receptor D3 |
U-78517F |
Dopamine D3 |
76% |
5.196uM |
1.765uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CLOTRIMAZOLE |
Calcium Channel Type L, Phenylalkylamine |
76% |
2.478uM |
2.41uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
adrenergic receptor, alpha 2b |
GUANFACINE |
Adrenergic alpha2C |
75% |
6.447uM |
.937uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
GUANFACINE |
Adrenergic alpha2C |
75% |
6.447uM |
.937uM |
View
|
adrenergic receptor, alpha 1a |
VERAPAMIL |
Adrenergic alpha1A |
75% |
2.092uM |
.847uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
2-ACETYLAMINOFLUORENE |
Adrenergic, Norepinephrine Transporter |
75% |
8.595uM |
8.524uM |
View
|
A3 adenosine receptor |
MITOTANE |
Adenosine A3 |
75% |
7.445uM |
4.208uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Adrenergic, Norepinephrine Transporter |
75% |
.786uM |
.78uM |
View
|
5-hydroxytryptamine receptor 6 |
PROPRANOLOL |
Serotonin 5-HT6 |
75% |
3.065uM |
1.423uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
MITOXANTRONE |
Serotonin 5-HT2C |
75% |
3.5619uM |
1.8657uM |
View
|
adrenergic receptor, alpha 2b |
IRINOTECAN |
Adrenergic alpha2C |
75% |
3.171uM |
.461uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
IRINOTECAN |
Adrenergic alpha2C |
75% |
3.171uM |
.461uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
QUINACRINE |
Adrenergic, Norepinephrine Transporter |
75% |
2.896uM |
2.872uM |
View
|
adenosine A2a receptor |
IMIQUIMOD |
Adenosine A2A |
75% |
5.32uM |
2.987uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
KETOTIFEN |
Serotonin 5-HT1A |
75% |
2.537uM |
1.45uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
KETOTIFEN |
Adrenergic alpha1D |
75% |
3.727uM |
1.832uM |
View
|
Sigma-2 Receptor |
SERTRALINE |
Sigma2 |
75% |
2.119uM |
1.304uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
NORTRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.803uM |
2.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
NORTRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.803uM |
2.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
NORTRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.803uM |
2.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
NORTRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.803uM |
2.492uM |
View
|